Sabrina Garbo | Ricerc@Sapienza

Pubblicazioni

Titolo	Pubblicato in	Anno
First-in-Class Selenium-Containing Potent Serotonin Receptor 5-HT6 Agents with a Beneficial Neuroprotective Profile against Alzheimer's Disease	JOURNAL OF MEDICINAL CHEMISTRY	2024
Selenium-containing compounds: a new hope for innovative treatments in Alzheimer’s disease and Parkinson’s disease	DRUG DISCOVERY TODAY	2024
m6A modification inhibits miRNAs’ intracellular function, favoring their extracellular export for intercellular communication	CELL REPORTS	2024
Unlocking the potential of higher-molecular-weight 5-HT7R ligands: Synthesis, affinity, and ADMET examination	BIOORGANIC CHEMISTRY	2024
Novel 1,4-Dihydropyridines as Specific Binders and Activators of SIRT3 Impair Cell Viability and Clonogenicity and Downregulate Hypoxia-Induced Targets in Cancer Cells	JOURNAL OF MEDICINAL CHEMISTRY	2023
SYNCRIP Modulates the Epithelial-Mesenchymal Transition in Hepatocytes and HCC Cells	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES	2022
Next RNA therapeutics: the mine of non-coding	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES	2022
Seleno-vs. thioether triazine derivatives in search for new anticancer agents overcoming multidrug resistance in lymphoma	EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY	2022
Restoration of WT1/miR-769-5p axis by HDAC1 inhibition promotes MMT reversal in mesenchymal-like mesothelial cells	CELL DEATH & DISEASE	2022
MyoD-Induced Trans-Differentiation: A Paradigm for Dissecting the Molecular Mechanisms of Cell Commitment, Differentiation and Reprogramming	CELLS	2022
Selenium-Containing Agents Acting on Cancer—A New Hope?	PHARMACEUTICS	2022
lncRNA HOTAIR functions and therapeutic perspectives	ONCOSCIENCE	2022
m6A RNA methylation and beyond - the epigenetic machinery and potential treatment options	DRUG DISCOVERY TODAY	2021
A novel RNA-based approach to counteract EMT	ONCOSCIENCE	2021
Design and functional validation of a mutant variant of the lncRNA HOTAIR to counteract Snail function in Epithelial-to-Mesenchymal Transition	CANCER RESEARCH	2020
The lncRNA H19 positively affects the tumorigenic properties of glioblastoma cells and contributes to NKD1 repression through the recruitment of EZH2 on its promoter	ONCOTARGET	2018